Monopar Therapeutics Inc. (MNPR) Live Share Price, Invest From India

Monopar Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$65.00
Day's Price Range
$67.30
$67.47
3.66%
Downside
-0.25%
Upside
52 Week's Low
52 Week's High
$29.18
52-Week Price Range
$105.00
$67.47
56.75%
Downside
55.62%
Upside

Monopar Therapeutics Inc. share price movements today

Previous Close: $64.39
Open: $66.38
Volume: 182.3K
Day's Low - High: $65.00 - $67.30
52 Week Low - High: $29.18 - $105.00

Monopar Therapeutics Inc. Historical Returns

1 Month Return: + 22.23 %
3 Month Return: + 15 %
1 Year Return: + 104.45 %
3 Year Return: + 1399.83 %
5 Year Return: + 132.25 %

Monopar Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Monopar Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$431.4M

EPS (TTM)

-2.9037

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-15.86%

Monopar Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Monopar Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Monopar Therapeutics Inc.	BUY	$431.4M	132.25%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Monopar Therapeutics Inc. Stock including INR - Dollar returns

The Monopar Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Monopar Therapeutics Inc. investment value today

Current value as on today

₹2,22,041

Returns

₹1,22,041

(+122.04%)

Returns from Monopar Therapeutics Inc. Stock

₹1,04,455 (+104.45%)

Dollar Impact

₹17,586 (+17.59%)

Analyst Recommendation on Monopar Therapeutics Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Monopar Therapeutics Inc.. Average target price of $112.62

Monopar Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Monopar Therapeutics Inc..

What analysts predicted

40.09%UPSIDE

Target Price

$112.62

Current Price

$67.47

Analyzed by

8 Analysts

Target

$112.62

Monopar Therapeutics Inc. target price $112.62, a slight upside of 40.09% compared to current price of $67.47. According to 8 analysts rating.

Indian Investors' Interest in Monopar Therapeutics Inc. Stock

Search interest for Monopar Therapeutics Inc. Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:67% versus previous 30 day period

Monopar Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-1	-1	-1	-1	-11	-3	-3	-4	-6	-5
EBITDA	0	-1	-1	-1	-10	-2	-2	-4	-5	-3
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-1	-1	-1	-1	-10	-2	-2	-3	-5	-3
Income Tax Expense	0	-1	-1	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-1	-10	-2	-2	-3	-5	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Monopar Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	0	-	-	-	-	-
Gross Profit	-	-	-	-	0	-	-	-	-	-
Operating Income	-1	-16	-3	-4	-6	-9	-10	-8	-16	-16
EBITDA	-1	-16	-3	-4	-6	-9	-10	-8	-15	-13
Interest Expense	0	0	0	0	0	0	0	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-1	-16	-3	-4	-6	-9	-10	-8	-15	-13
Income Tax Expense	0	-2	0	0	0	0	0	0	-	-
Net Income	-1	-16	-3	-4	-6	-9	-10	-8	-15	-13
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-5150.79%	0.00%	0.00%	0.00%	0.00%	0.00%

Monopar Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-1	-1	-1	-10	-2	-2	-3	-5	-3
Operating Cash Flow	-1	-1	-1	-1	-5	-1	-2	-3	-3
Investing Cash Flow	0	0	0	-14	0	1	-2	-62	-5
Financing Cash Flow	3	0	0	56	0	0	92	0	0
Change in Cash	0	-1	0	39	-6	0	88	-65	-9

Monopar Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-3	-4	-6	-9	-10	-8	-15	-13
Operating Cash Flow	-2	-2	-3	-4	-7	-7	-7	-6	-12
Investing Cash Flow	-	-	-	-	-	-4	4	-14	-63
Financing Cash Flow	9	0	9	8	10	0	2	59	91
Change in Cash	6	-2	6	3	3	-12	0	38	16

Global Institutional Holdings in Monopar Therapeutics Inc.

Funds	Holdings
TCG Crossover Management, LLC	1.97%
Charles Schwab Investment Management Inc	0.21%
ADAR1 Capital Management LLC	3.94%
Susquehanna International Group, LLP	0.14%
Barclays PLC	0.12%

See all

Monopar Therapeutics Inc. News & Key Events

Insights on Monopar Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, MNPR has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MNPR has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, MNPR stock has moved up by 1451.0%

About Monopar Therapeutics Inc.

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a Phase1a stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; Excel Diagnostics and Nuclear Oncology Center, for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu; license agreement with Alexion to develop and commercialize ALXN1840, a drug candidate for Wilson disease. The company was founded in 2014 and is headquartered in Wilmette, Illinois.

Organisation	Monopar Therapeutics Inc.
Headquarters	1000 Skokie Boulevard, Wilmette, IL, United States, 60091
Industry	Biotechnology
CEO	Dr. Chandler D. Robinson M.B.A., M.D., M.Sc.
E-voting on shares	Click here to vote

Key Management of Monopar Therapeutics Inc.

Name	Title
Dr. Christopher M. Starr Ph.D.	Co-Founder & Independent Executive Chairman of the Board
Dr. Chandler D. Robinson M.B.A., M.D., M.Sc.	Co-Founder, CEO, President & Director
Mr. Quan Anh Vu	CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer
Mr. Andrew J. Cittadine M.B.A.	Chief Operating Officer
Dr. Patrice P. Rioux M.D., Ph.D.	Acting Chief Medical Officer
Ms. Susan Rodriguez	Chief Commercial & Strategy Officer

FAQs

What is Monopar Therapeutics Inc. share price today?

Monopar Therapeutics Inc. share price today is $67.47 as on June 19, 2026 at 8:45 am IST at the close of the market. Monopar Therapeutics Inc. share today touched a day high of $67.3 and a low of $65.

What is the 52 week high and 52 week low for Monopar Therapeutics Inc. share?

Monopar Therapeutics Inc. share touched a 52 week high of $105 on October 6, 2025 and a 52 week low of $29.18 on August 26, 2025. Monopar Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $67.47,which is 35.74% down from its 52 week high and 131.22% up from its 52 week low.

What is Monopar Therapeutics Inc.'s market capitalisation today?

Monopar Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Monopar Therapeutics Inc. Stock (MNPR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Monopar Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Monopar Therapeutics Inc. Shares that will get you 0.0222 shares as per Monopar Therapeutics Inc. share price of $67.47 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Monopar Therapeutics Inc. Stock (MNPR) from India?

Indian investors can start investing in Monopar Therapeutics Inc. (MNPR) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 7:47 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Monopar Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 7:47 am IST). Based on Monopar Therapeutics Inc. share’s latest price of $67.47 as on June 19, 2026 at 8:45 am IST, you will get 0.1482 shares of Monopar Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Monopar Therapeutics Inc. has given to Indian investors in the last 5 years?

Monopar Therapeutics Inc. stock has given 132.25% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?